Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ingreland is a synthetic biology company based in Beijing that focuses on the sustainable production of high-value natural ingredients for the healthcare, cosmetics, and nutrition sectors. The company leverages a proprietary metabolic engineering platform and microbial cell factories to manufacture bioactive compounds such as ergothioneine, ectoine, and rare ginsenosides. By utilizing bio-fermentation, Ingreland provides an eco-friendly and efficient alternative to traditional chemical synthesis and plant extraction methods. The firm has successfully transitioned multiple products from laboratory development to large-scale industrial manufacturing. Ingreland's mission is to drive the green transformation of the global raw materials industry through advanced biotechnology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ingreland.